158 related articles for article (PubMed ID: 36325337)
21. [Salvage HIFU after radiotherapy and salvage radiotherapy after HIFU in locally recurrent prostate cancer: Retrospective analysis of morbidity].
Lee JW; Chevallier D; Gal J; Rouscoff Y; Natale R; Chand ME; Raffaelli C; Ambrosetti D; Durand M; Amiel J; Hannoun-Levi JM
Prog Urol; 2014 Dec; 24(16):1076-85. PubMed ID: 25241245
[TBL] [Abstract][Full Text] [Related]
22. High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients.
Schaudinn A; Michaelis J; Franz T; Ho-Thi P; Horn LC; Blana A; Hadaschik B; Stumpp P; Stolzenburg JU; Schlemmer HP; Denecke T; Busse H; Ganzer R; Linder N
Eur J Radiol; 2021 Nov; 144():109957. PubMed ID: 34601322
[TBL] [Abstract][Full Text] [Related]
23. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer.
Warmuth M; Johansson T; Mad P
Eur Urol; 2010 Dec; 58(6):803-15. PubMed ID: 20864250
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of local salvage therapy for recurrent uterine cervical cancer after definitive radiotherapy.
Hiraoka S; Nakajima A; Kishi N; Takehana K; Hanazawa H; Matsuo Y; Mizowaki T
Int J Clin Oncol; 2021 Oct; 26(10):1968-1976. PubMed ID: 34165659
[TBL] [Abstract][Full Text] [Related]
25. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery.
Lee YS; Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Tumori; 2010; 96(4):553-9. PubMed ID: 20968134
[TBL] [Abstract][Full Text] [Related]
27. [When Should We Perform Surgery for N2 Lung Cancer?;Induction Chemoradiotherapy or Surgery for Local Recurrence or Residual Tumor after Definitive Chemoradiotherapy].
Ito H; Nakayama H
Kyobu Geka; 2018 Apr; 71(4):290-299. PubMed ID: 29755103
[TBL] [Abstract][Full Text] [Related]
28. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study.
Liu X; Tang J; Luo Y; Wang Y; Song L; Wang W
BJOG; 2020 Oct; 127(11):1422-1428. PubMed ID: 32285586
[TBL] [Abstract][Full Text] [Related]
29. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
[TBL] [Abstract][Full Text] [Related]
30. HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial.
Yang T; Ng DM; Du N; He N; Dai X; Chen P; Wu F; Chen B; Fan X; Yan K; Zhou X; Dong M; Zheng Z; Gu L
Surg Endosc; 2021 May; 35(5):2306-2315. PubMed ID: 32435962
[TBL] [Abstract][Full Text] [Related]
31. Completion surgery after chemoradiotherapy for cervical cancer - is there a role? UK Cancer Centre experience of hysterectomy post chemo-radiotherapy treatment for cervical cancer.
Platt SL; Patel A; Humphrey PJ; Al-Booz H; Bailey J
J Obstet Gynaecol; 2019 Jan; 39(1):68-73. PubMed ID: 30230397
[TBL] [Abstract][Full Text] [Related]
32. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
33. Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.
Holtzman AL; Hoppe BS; Letter HP; Bryant C; Nichols RC; Henderson RH; Mendenhall WM; Morris CG; Williams CR; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):465-471. PubMed ID: 26883560
[TBL] [Abstract][Full Text] [Related]
34. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
[TBL] [Abstract][Full Text] [Related]
35. Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma.
Chan AC; Cheung TT; Fan ST; Chok KS; Chan SC; Poon RT; Lo CM
Ann Surg; 2013 Apr; 257(4):686-92. PubMed ID: 23426335
[TBL] [Abstract][Full Text] [Related]
36. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
[TBL] [Abstract][Full Text] [Related]
37. Significance of HIFU in local unresectable recurrence of soft tissue sarcoma, a single-center, respective, case series in China.
Yu W; Tang L; Lin F; Jiang L; Shen Z
Surg Oncol; 2019 Sep; 30():117-121. PubMed ID: 31500773
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
39. Can pre- and postoperative magnetic resonance imaging predict recurrence-free survival after whole-gland high-intensity focused ablation for prostate cancer?
Rosset R; Bratan F; Crouzet S; Tonoli-Catez H; Mège-Lechevallier F; Gelet A; Rouvière O
Eur Radiol; 2017 Apr; 27(4):1768-1775. PubMed ID: 27436018
[TBL] [Abstract][Full Text] [Related]
40. [Local recurrence of prostate cancer after curative therapy. HIFU (Ablatherm) as a treatment option].
Chaussy C; Thüroff S; Bergsdorf T
Urologe A; 2006 Oct; 45(10):1271-5. PubMed ID: 17006697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
